Applied Health Economics and Health Policy This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Correction to: Incidence of Catastrophic Health Expenditure and Its Determinants in Cancer Patients: A Systematic Review and Meta ‑analysis
(Source: Applied Health Economics and Health Policy)
Source: Applied Health Economics and Health Policy - October 7, 2021 Category: Health Management Source Type: research

COVID-19 Vaccine Demand and Financial Incentives
ConclusionsUS individuals highly value the COVID-19 vaccine, and about 88% of the US population would accept the vaccination; however, 14% indicated they would get vaccinated if compensated. Payments of about US$500 or more would be needed to sufficiently incentivize 50% or more of this group vaccinated. (Source: Applied Health Economics and Health Policy)
Source: Applied Health Economics and Health Policy - October 5, 2021 Category: Health Management Source Type: research

The Cost Effectiveness of Taxation of Sugary Foods and Beverages: A Systematic Review of Economic Evaluations
ConclusionsSugar tax is a practical and cost-effective policy option to reduce the health and economic burden resulting from excess sugar consumption. The impact of sugar taxes depends on the target population, time horizons, and other parameters. Economic evaluations of taxation of a broader set of sugary products and economic evaluations that combine sugar taxation with other interventions are important to inform further action to curb sugar consumption. (Source: Applied Health Economics and Health Policy)
Source: Applied Health Economics and Health Policy - October 5, 2021 Category: Health Management Source Type: research

Indirect and Direct Mapping of the Cancer-Specific EORTC QLQ-C30 onto EQ-5D-5L Utility Scores
ConclusionThe developed mapping algorithms enable the prediction of EQ-5D-5L utilities from QLQ-C30 scores when EQ-5D-5L data have not been directly collected in clinical trials. The response mapping model offers the possibility of predicting EQ-5D-5L utility values using any national value set and can be generalised to multiple countries and oncology settings. (Source: Applied Health Economics and Health Policy)
Source: Applied Health Economics and Health Policy - September 23, 2021 Category: Health Management Source Type: research

Pricing and Reimbursement of Patent-Protected Medicines: Challenges and Lessons from South-Eastern Europe
ConclusionsFurther reforms aiming to develop transparent and robust national decision-making frameworks (including oversight) and build institutional HTA-related and decision-making capacity are awaited in most of SEE countries, especially the non-EU members. In non-EU SEE countries, these efforts could increase access to patent-protected medicines, which is —at the moment—very limited. The EU-member SEE countries operate more developed P&R systems but could further benefit from developing their procedures, oversight and value-for-money assessment toolbox and capacity, hence further improving the transparency and e...
Source: Applied Health Economics and Health Policy - September 23, 2021 Category: Health Management Source Type: research

Towards a Broader Assessment of Value in Vaccines: The BRAVE Way Forward
ConclusionTo achieve a broader recognition of the value of vaccines, a three-pronged approach was recommended, focusing on (1)Evidence: proactively steering generation of high-quality evidence to quantify the broader value of vaccines to society; (2)Ability: leveraging and further developing existing methodological and analytic expertise to appropriately recognise the broad value of vaccines within HTA processes; (3)Willingness: Stimulating stakeholder engagement to change the status quo and move towards more transparent and comprehensive value assessment processes for vaccines globally. (Source: Applied Health Economics and Health Policy)
Source: Applied Health Economics and Health Policy - September 23, 2021 Category: Health Management Source Type: research

Avoiding Opportunity Cost Neglect in Cost-Effectiveness Analysis for Health Technology Assessment
AbstractDespite being a fundamental tenet of economic analysis there is a lack of clarity regarding the relevance of opportunity costs to cost-effectiveness analysis for health technology assessment. We argue that this is due, in part, to the importance of the decision context in understanding the nature of opportunity costs. Taking the example of the National Institute of Health and Care Excellence (NICE) on behalf of the National Health Service (NHS) in England and Wales, we explore the implications of existing discrepancies between policy thresholds and emerging empirical evidence of health opportunity costs. In particu...
Source: Applied Health Economics and Health Policy - September 1, 2021 Category: Health Management Source Type: research

Strategies for Avoiding Neglect of Opportunity Costs by Decision-Makers
(Source: Applied Health Economics and Health Policy)
Source: Applied Health Economics and Health Policy - September 1, 2021 Category: Health Management Source Type: research

Integrated Care in Europe: Time to Get it Together?
(Source: Applied Health Economics and Health Policy)
Source: Applied Health Economics and Health Policy - August 30, 2021 Category: Health Management Source Type: research

Costs and Cost-Effectiveness of User-Testing of Health Professionals ’ Guidelines to Reduce the Frequency of Intravenous Medicines Administration Errors by Nurses in the United Kingdom: A Probabilistic Model Based on Voriconazole Administration
ConclusionsUser-testing of injectable medicines guidelines is a low-cost intervention that is highly likely to be cost-effective, especially for high-risk medicines. (Source: Applied Health Economics and Health Policy)
Source: Applied Health Economics and Health Policy - August 17, 2021 Category: Health Management Source Type: research

Budget Impact Analysis of the Introduction of Subcutaneous Infliximab (CT-P13 SC) for the Treatment of Rheumatoid Arthritis in the United Kingdom
ConclusionUse of CT-P13 SC may lead to substantial cost savings for the UK society. (Source: Applied Health Economics and Health Policy)
Source: Applied Health Economics and Health Policy - August 12, 2021 Category: Health Management Source Type: research

Economic Evaluation of an Intervention Designed to Reduce Bullying in Australian Schools
ConclusionsThe Friendly Schools Friendly Families anti-bullying intervention represents a good investment compared to usual activities for the management of child and adolescent bullying in Australia. The investment and implementation of evidence-based interventions that reduce bullying victimisation and bullying perpetration in schools could reduce the economic burden associated with common mental health disorders and thereby improve the health of many Australians. (Source: Applied Health Economics and Health Policy)
Source: Applied Health Economics and Health Policy - August 9, 2021 Category: Health Management Source Type: research

Approaches to Measure Efficiency in Primary Care: A Systematic Literature Review
ConclusionsThe main limitations that future research on primary care efficiency should address relate to the definition of output. Current approaches to measure the impact on health and the multiple dimensions of output are not sufficient to represent the valued output of primary care. In light of the recent changes in the model of primary care delivery in England, future research should  also investigate the impact of technological change on productivity and the scope for substitution across staff roles. (Source: Applied Health Economics and Health Policy)
Source: Applied Health Economics and Health Policy - August 5, 2021 Category: Health Management Source Type: research

Quality of Health Economic Evaluations in Mainland China: A Comparison of Peer-Reviewed Articles in Chinese and in English
ConclusionThe quality of reporting of health economic evaluations in mainland China has developed slowly. Most of the included studies were incomplete in the presentation of content, making the results less reliable. It is important to standardize and improve the quality of Chinese health economic research. (Source: Applied Health Economics and Health Policy)
Source: Applied Health Economics and Health Policy - July 29, 2021 Category: Health Management Source Type: research

Incidence of Catastrophic Health Expenditure and Its Determinants in Cancer Patients: A Systematic Review and Meta-analysis
ConclusionThe proportion of cancer patients that incur CHE is very high, especially in countries with lower HDI. The results from this review can help inform policy makers to develop fairer and more sustainable health financing mechanisms, addressing the factors associated with CHE in cancer patients. (Source: Applied Health Economics and Health Policy)
Source: Applied Health Economics and Health Policy - July 28, 2021 Category: Health Management Source Type: research